Catalyst Wire Dossier Catalyst Wire Dossier

Sumatriptan/naproxen sodium combination product

sumatriptan/naproxen sodium · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sumatriptan/naproxen sodium combination product, covering 2012-08-27 to 2012-08-27. Get the full timeline:

Most recent: Clinical Trial Update: Impact of Migraine on Work Productivity in Patients Treated With a Combination Product Containing Sumatriptan and Naproxen Sodium or Triptan Monotherapy

See pricing